Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (15623)
All Articles published online
|
Publishing Process of This Article
|
Aug 7, 2014 (publication date) through Nov 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Panczyk M. Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years. World J Gastroenterol 2014; 20(29): 9775-9827 [PMID: 25110414 DOI: 10.3748/wjg.v20.i29.9775] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v20/i29/9775.htm |
| Number | Citing Articles |
| 1 |
Anastasios Ntavatzikos, Aris Spathis, Paul Patapis, Nikolaos Machairas, George Peros, Stefanos Konstantoudakis, Danai Leventakou, Ioannis G Panayiotides, Petros Karakitsos, Anna Koumarianou. Integrating <i>TYMS</i>, <i>KRAS</i> and <i>BRAF</i> testing in patients with metastatic colorectal cancer. World Journal of Gastroenterology 2017; 23(32): 5913-5924 doi: 10.3748/wjg.v23.i32.5913
|
| 2 |
Vânia Diogo, Joana Teixeira, Patrícia M.A. Silva, Hassan Bousbaa. Spindle Assembly Checkpoint as a Potential Target in Colorectal Cancer: Current Status and Future Perspectives. Clinical Colorectal Cancer 2017; 16(1): 1 doi: 10.1016/j.clcc.2016.06.006
|
| 3 |
Amirreza Hesari, Amir Maleksabet, Abolfazl Nosrati Tirkani, Hamideh Ghazizadeh, Elmira Iranifar, Fatoalah Mohagheg, Ali Arash Anoshrvani, Faezeh Ghasemi. Evaluation of the two polymorphisms rs1801133 in MTHFR and rs10811661 in CDKN2A/B in breast cancer. Journal of Cellular Biochemistry 2019; 120(2): 2090 doi: 10.1002/jcb.27517
|
| 4 |
Sona Vodenkova, Tomas Buchler, Klara Cervena, Veronika Veskrnova, Pavel Vodicka, Veronika Vymetalkova. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future. Pharmacology & Therapeutics 2020; 206: 107447 doi: 10.1016/j.pharmthera.2019.107447
|
| 5 |
Peilong Li, Xin Zhang, Lili Wang, Lutao Du, Yongmei Yang, Tong Liu, Chen Li, Chuanxin Wang. lncRNA HOTAIR Contributes to 5FU Resistance through Suppressing miR-218 and Activating NF-κB/TS Signaling in Colorectal Cancer. Molecular Therapy - Nucleic Acids 2017; 8: 356 doi: 10.1016/j.omtn.2017.07.007
|
| 6 |
João Crispim Encarnação, Ana Salomé Pires, Renata Alexandra Amaral, Telmo José Gonçalves, Mafalda Laranjo, João Eduardo Casalta-Lopes, Ana Cristina Gonçalves, Ana Bela Sarmento-Ribeiro, Ana Margarida Abrantes, Maria Filomena Botelho. Butyrate, a dietary fiber derivative that improves irinotecan effect in colon cancer cells. The Journal of Nutritional Biochemistry 2018; 56: 183 doi: 10.1016/j.jnutbio.2018.02.018
|
| 7 |
Xin-Xin Wang, Peng-cheng Yu, Jun Li. High-Throughput Metabolomics for Identification of Metabolic Pathways and Deciphering the Effect Mechanism of Dioscin on Rectal Cancer From Cell Metabolic Profiles Coupled With Chemometrics Analysis. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00068
|
| 8 |
Hwani Ryu, Ky-Youb Nam, Hyo Jeong Kim, Jie-Young Song, Sang-Gu Hwang, Jae Sung Kim, Joon Kim, Jiyeon Ahn. Discovery of a Novel Triazolopyridine Derivative as a Tankyrase Inhibitor. International Journal of Molecular Sciences 2021; 22(14): 7330 doi: 10.3390/ijms22147330
|
| 9 |
Hiroyuki Fujikawa, Yuji Toiyama, Yasuhiro Inoue, Yusuke Omura, Shozo Ide, Takahito Kitajima, Hiromi Yasuda, Yoshinaga Okugawa, Yoshiki Okita, Shigeyuki Yoshiyama, Junichiro Hiro, Minako Kobayashi, Masaki Ohi, Toshimitsu Araki, Masato Kusunoki. Phase�I study of preoperative chemoradiotherapy with sequential oxaliplatin and irinotecan with S‑1 for locally advanced rectal cancer. Oncology Letters 2019; doi: 10.3892/ol.2019.10028
|
| 10 |
Chi-Che Hsieh, Ting-Wei Li, Chun-Chun Li, Shang-Hung Chen, You-Lin Wei, Nai-Jung Chiang, Che-Hung Shen. DKK1 as a chemoresistant protein modulates oxaliplatin responses in colorectal cancer. Oncogenesis 2024; 13(1) doi: 10.1038/s41389-024-00537-y
|
| 11 |
Ziyu Li, Xiaofang Xing, Fei Shan, Shuangxi Li, Zhongwu Li, Aitang Xiao, Zhaodong Xing, Kan Xue, Zhemin Li, Ying Hu, Yongning Jia, Rulin Miao, Lianhai Zhang, Zhaode Bu, Aiwen Wu, Jiafu Ji. ABCC2-24C > T polymorphism is associated with the response to platinum/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patients. Oncotarget 2016; 7(34): 55449 doi: 10.18632/oncotarget.10961
|
| 12 |
Linrong Pang, Jinger Lu, Jia Huang, Caihong Xu, Hui Li, Guangbo Yuan, Xiaochun Cheng, Jun Chen. Upregulation of miR‑146a increases cisplatin sensitivity of the non‑small cell lung cancer A549 cell line by targeting JNK‑2. Oncology Letters 2017; doi: 10.3892/ol.2017.7242
|
| 13 |
Francis Yew Fu Tieng, Rashidah Baharudin, Nadiah Abu, Ryia-Illani Mohd Yunos, Learn-Han Lee, Nurul-Syakima Ab Mutalib. Single Cell Transcriptome in Colorectal Cancer—Current Updates on Its Application in Metastasis, Chemoresistance and the Roles of Circulating Tumor Cells. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00135
|
| 14 |
Ko-Chao Lee, Chien-Tsong Lin, Shun-Fu Chang, Cheng-Nan Chen, Jing-Lan Liu, Wen-Shih Huang. Effect of AICAR and 5-Fluorouracil on X-ray Repair, Cross-Complementing Group 1 Expression, and Consequent Cytotoxicity Regulation in Human HCT-116 Colorectal Cancer Cells. International Journal of Molecular Sciences 2017; 18(11): 2363 doi: 10.3390/ijms18112363
|
| 15 |
Mahshid Mohammadian, Shima Zeynali-Moghaddam, Mohammad Hassan Khadem Ansari, Yousef Rasmi, Anahita Fathi Azarbayjani, Fatemeh Kheradmand. Dihydropyrimidine Dehydrogenase Levels in Colorectal Cancer Cells Treated with a Combination of Heat Shock Protein 90 Inhibitor and Oxaliplatin or Capecitabine. Advanced Pharmaceutical Bulletin 2019; 9(3): 439 doi: 10.15171/apb.2019.052
|
| 16 |
Ane Sørlie Kværner, Jun Minaguchi, Naouale El Yamani, Christine Henriksen, Hanna Ræder, Ingvild Paur, Hege Berg Henriksen, Gro Wiedswang, Sigbjørn Smeland, Rune Blomhoff, Andrew Richard Collins, Siv Kjølsrud Bøhn. DNA damage in blood cells in relation to chemotherapy and nutritional status in colorectal cancer patients—A pilot study. DNA Repair 2018; 63: 16 doi: 10.1016/j.dnarep.2018.01.005
|
| 17 |
Goretti Duran, Raquel Cruz, Ana Rita Simoes, Francisco Barros, José María Giráldez, Beatriz Bernárdez, Urbano Anido, Sonia Candamio, Rafael López-López, Ángel Carracedo, María Jesús Lamas. Efficacy and toxicity of adjuvant chemotherapy on colorectal cancer patients: how much influence from the genetics?. Journal of Chemotherapy 2020; 32(6): 310 doi: 10.1080/1120009X.2020.1764281
|
| 18 |
Joske Ubels, Tilman Schaefers, Cornelis Punt, Henk-Jan Guchelaar, Jeroen de Ridder. RAINFOREST: a random forest approach to predict treatment benefit in data from (failed) clinical drug trials. Bioinformatics 2020; 36(Supplement_2): i601 doi: 10.1093/bioinformatics/btaa799
|
| 19 |
Gozde Hasbal‑Celikok, Pinar Aksoy‑sagirli, Gulsum Altiparmak‑Ulbegi, Ayse Can. Identification of AKT1/β-catenin mutations conferring cetuximab and chemotherapeutic drug resistance in colorectal cancer treatment. Oncology Letters 2021; 21(3) doi: 10.3892/ol.2021.12470
|
| 20 |
Sujit Nair, Ah-Ng Tony Kong. Architecture of Signature miRNA Regulatory Networks in Cancer Chemoprevention. Current Pharmacology Reports 2015; 1(2): 89 doi: 10.1007/s40495-014-0014-6
|
| 21 |
Nelly Miteva-Marcheva, Hristo Ivanov, Veselin Popov, Gabriela Raycheva, Zhanet Grudeva-Popova, Vili Stoyanova. Liquid biopsy: an innovative and reliable method for detecting not only somatic, but also germline mutations in patients with colorectal and non-small cell lung carcinoma. Biotechnology & Biotechnological Equipment 2023; 37(1) doi: 10.1080/13102818.2023.2249560
|
| 22 |
Guolin Zhang, Xin Luo, Zian Wang, Jianbin Xu, Wei Zhang, Engeng Chen, Qing Meng, Di Wang, Xuefeng Huang, Wei Zhou, Zhangfa Song. TIMP-2 regulates 5-Fu resistance via the ERK/MAPK signaling pathway in colorectal cancer. Aging 2022; 14(1): 297 doi: 10.18632/aging.203793
|
| 23 |
Zehua Bian, Yuyang Feng, Yao Xue, Yaling Hu, Qifeng Wang, Leyuan Zhou, Zhihui Liu, Jiwei Zhang, Yuan Yin, Bing Gu, Zhaohui Huang. Down-regulation of SNX1 predicts poor prognosis and contributes to drug resistance in colorectal cancer. Tumor Biology 2016; 37(5): 6619 doi: 10.1007/s13277-015-3814-3
|
| 24 |
William A. Hammond, Abhisek Swaika, Kabir Mody. Pharmacologic resistance in colorectal cancer: a review. Therapeutic Advances in Medical Oncology 2016; 8(1): 57 doi: 10.1177/1758834015614530
|
| 25 |
Isaac Micallef, Byron Baron. The Mechanistic Roles of ncRNAs in Promoting and Supporting Chemoresistance of Colorectal Cancer. Non-Coding RNA 2021; 7(2): 24 doi: 10.3390/ncrna7020024
|
| 26 |
MIKA HOSOKAWA, MAI SAITO, AIKO NAKANO, SAKURA IWASHITA, AYANO ISHIZAKA, KUMIKO UEDA, SEIGO IWAKAWA. Acquired resistance to decitabine and cross-resistance to gemcitabine during the long-term treatment of human HCT116 colorectal cancer cells with decitabine. Oncology Letters 2015; 10(2): 761 doi: 10.3892/ol.2015.3253
|
| 27 |
Lei Zhu, Jianfeng Cao, Guochuang Chen, Yanghui Xu, Jingbo Lu, Fang Fang, Kaoshan Chen. Anti-tumor and immunomodulatory activities of an exopolysaccharide from Rhizopus nigricans on CT26 tumor-bearing mice. International Immunopharmacology 2016; 36: 218 doi: 10.1016/j.intimp.2016.04.033
|
| 28 |
Jonathan Escalante, Rachel M. McQuade, Vanesa Stojanovska, Kulmira Nurgali. Impact of chemotherapy on gastrointestinal functions and the enteric nervous system. Maturitas 2017; 105: 23 doi: 10.1016/j.maturitas.2017.04.021
|
| 29 |
Jie Dou, Zhou Wang, Leon Ma, Bo Peng, Ke Mao, Chengqin Li, Mengqi Su, Changlin Zhou, Guangyong Peng. Baicalein and baicalin inhibit colon cancer using two distinct fashions of apoptosis and senescence. Oncotarget 2018; 9(28): 20089 doi: 10.18632/oncotarget.24015
|
| 30 |
Chunhong Zhang, Yangjie Xu, Haowen Wang, Gang Li, Han Yan, Zhenghua Fei, Yunsheng Xu, Wenfeng Li. Curcumin reverses irinotecan resistance in colon cancer cell by regulation of epithelial–mesenchymal transition. Anti-Cancer Drugs 2018; 29(4): 334 doi: 10.1097/CAD.0000000000000599
|
| 31 |
Hua Zhao, Li Xiong, Wen-Jun Yi, Zhen-Dong Lei, San-Lin Lei, Hong-Liang Yao, Kui-Jie Liu, Si-Qi Zhang. Photodynamic therapy as salvage therapy for residual microscopic cancer after ultra-low anterior resection: A case report. World Journal of Clinical Cases 2019; 7(6): 798-804 doi: 10.12998/wjcc.v7.i6.798
|
| 32 |
Gui-wei Liu, Yan-hua Liu, Guo-sheng Jiang, Wei-dan Ren. The reversal effect of Ginsenoside Rh2 on drug resistance in human colorectal carcinoma cells and its mechanism. Human Cell 2018; 31(3): 189 doi: 10.1007/s13577-017-0189-3
|
| 33 |
Jungyoun Kim, Yeyeong Jeong, You Me Shin, Sung Eun Kim, Sang Joon Shin. FL118 Enhances Therapeutic Efficacy in Colorectal Cancer by Inhibiting the Homologous Recombination Repair Pathway through Survivin–RAD51 Downregulation. Cancers 2024; 16(19): 3385 doi: 10.3390/cancers16193385
|
| 34 |
Ya Wang, Qunhui Wei, Yuqiao Chen, Shichao Long, Yuanbing Yao, Kai Fu. Identification of Hub Genes Associated With Sensitivity of 5-Fluorouracil Based Chemotherapy for Colorectal Cancer by Integrated Bioinformatics Analysis. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.604315
|
| 35 |
Dongdong Luo, Xiaochun Liu, Leilei Jiang, Zhikun Guo, Yan Lv, Xiaochen Tian, Xiaoyan Wang, Shuxiang Cui, Shengbiao Wan, Xianjun Qu, Ximing Xu, Xiaoyang Li. Rational Design, Synthesis, and Biological Evaluation of Novel S1PR2 Antagonists for Reversing 5-FU-Resistance in Colorectal Cancer. Journal of Medicinal Chemistry 2022; 65(21): 14553 doi: 10.1021/acs.jmedchem.2c00958
|
| 36 |
Kha Wai Hon, Nadiah Abu, Nurul-Syakima Ab Mutalib, Rahman Jamal. miRNAs and lncRNAs as Predictive Biomarkers of Response to FOLFOX Therapy in Colorectal Cancer. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00846
|
| 37 |
Yan-Yan Zhu, Qiong Jin, Shan-Shan Chen, Dan-Ni Jin, Zhao-Jie Wang, Ying-Jie He, Hui-Cheng Chen, Yun-Li Zhao, Li-Xing Zhao, Zhi Dai, Xiao-Dong Luo. Neothalfine, a potent natural anti-tumor agent against metastatic colorectal cancer and its primary mechanism. Bioorganic & Medicinal Chemistry 2021; 29: 115849 doi: 10.1016/j.bmc.2020.115849
|
| 38 |
Grace Zdesenko, Takafira Mduluza, Francisca Mutapi. Pharmacogenetics of Praziquantel Metabolism: Evaluating the Cytochrome P450 Genes of Zimbabwean Patients During a Schistosomiasis Treatment. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.914372
|
| 39 |
Seyung S. Chung, Pranabananda Dutta, David Austin, Piwen Wang, Adam Awad, Jaydutt V. Vadgama. Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells. Oncotarget 2018; 9(68): 32943 doi: 10.18632/oncotarget.25993
|
| 40 |
Feng Wang, Xianfei Ding, Tao Wang, Zhengzheng Shan, Jun Wang, Shaoxuan Wu, Yanyan Chi, Yana Zhang, Zhuan Lv, Liuxing Wang, Qingxia Fan, Aamir Ahmad. Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin. PLOS ONE 2017; 12(4): e0174276 doi: 10.1371/journal.pone.0174276
|
| 41 |
Md Rashedul Islam, Md Abdul Awal, Ahmed Khames, Mohammad A. S. Abourehab, Abdus Samad, Walid M. I. Hassan, Rahat Alam, Osman I. Osman, Suza Mohammad Nur, Mohammad Habibur Rahman Molla, Abdulrasheed O. Abdulrahman, Sultana Rajia, Foysal Ahammad, Md Nazmul Hasan, Ishtiaq Qadri, Bonglee Kim. Computational Identification of Druggable Bioactive Compounds from Catharanthus roseus and Avicennia marina against Colorectal Cancer by Targeting Thymidylate Synthase. Molecules 2022; 27(7): 2089 doi: 10.3390/molecules27072089
|
| 42 |
Juan Pablo Cayún, Leslie Carol Cerpa, Alicia Colombo, Dante Daniel Cáceres, José Luis Leal, Felipe Reyes, Carolina Gutiérrez-Cáceres, Susan Calfunao, Nelson Miguel Varela, Luis Abel Quiñones. Genetic Polymorphisms and Tumoral Mutational Profiles over Survival in Advanced Colorectal Cancer Patients: An Exploratory Study. Current Oncology 2024; 31(1): 274 doi: 10.3390/curroncol31010018
|
| 43 |
Aurora Gazzillo, Camilla Volponi, Cristiana Soldani, Michela Anna Polidoro, Barbara Franceschini, Ana Lleo, Eduardo Bonavita, Matteo Donadon. Cellular Senescence in Liver Cancer: How Dying Cells Become “Zombie” Enemies. Biomedicines 2023; 12(1): 26 doi: 10.3390/biomedicines12010026
|
| 44 |
Adriana González, Iker Badiola, Asier Fullaondo, Javier Rodríguez, Adrian Odriozola. Advances in Host Genetics and Microbiome in Colorectal Cancer-Related Phenotypes. Advances in Genetics 2024; 112: 411 doi: 10.1016/bs.adgen.2024.08.004
|
| 45 |
Aritro Nath, Jacqueline Wang, R. Stephanie Huang. Pharmacogenetics and Pharmacogenomics of Targeted Therapeutics in Chronic Myeloid Leukemia. Molecular Diagnosis & Therapy 2017; 21(6): 621 doi: 10.1007/s40291-017-0292-x
|
| 46 |
Xingxing Huang, Kun Ke, Weiwei Jin, Qianru Zhu, Qicong Zhu, Ruyi Mei, Ruonan Zhang, Shuxian Yu, Lan Shou, Xueni Sun, Jiao Feng, Ting Duan, Yiping Mou, Tian Xie, Qibiao Wu, Xinbing Sui. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.887048
|
| 47 |
Hossein Moutabian, Mehrsa Majdaeen, Ruhollah Ghahramani-Asl, Masoumeh Yadollahi, Esmaeil Gharepapagh, Gholamreza Ataei, Zahra Falahatpour, Hamed Bagheri, Bagher Farhood. A systematic review of the therapeutic effects of resveratrol in combination with 5-fluorouracil during colorectal cancer treatment: with a special focus on the oxidant, apoptotic, and anti-inflammatory activities. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02561-7
|
| 48 |
Lisa A. Varughese, Kelsey S. Lau‐Min, Christine Cambareri, Nevena Damjanov, Ryan Massa, Nandi Reddy, Randall Oyer, Ursina Teitelbaum, Sony Tuteja. DPYD and UGT1A1 Pharmacogenetic Testing in Patients with Gastrointestinal Malignancies: An Overview of the Evidence and Considerations for Clinical Implementation. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2020; 40(11): 1108 doi: 10.1002/phar.2463
|
| 49 |
Raffaele Palmirotta, Claudia Carella, Erica Silvestris, Mauro Cives, Stefania Luigia Stucci, Marco Tucci, Domenica Lovero, Franco Silvestris. SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand. Oncotarget 2018; 9(38): 25355 doi: 10.18632/oncotarget.25256
|
| 50 |
Christopher W. Mangieri, Cristian D. Valenzuela, Ian B. Solsky, Richard A. Erali, Konstantinos I. Votanopoulos, Perry Shen, Edward A. Levine. Exposure to Neoadjuvant Oxaliplatin-Containing Chemotherapy, Does it Effect Intraperitoneal Hyperthermic Chemotherapy Perfusion?. Annals of Surgical Oncology 2023; 30(4): 2486 doi: 10.1245/s10434-022-12933-y
|
| 51 |
Jie Chai, Wei Dong, Chao Xie, Lin Wang, Da‐Li Han, Shan Wang, Hong‐Liang Guo, Zong‐Li Zhang. MicroRNA‐494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD. IUBMB Life 2015; 67(3): 191 doi: 10.1002/iub.1361
|
| 52 |
Yinghui Zhao, Chuanxin Wang, Ajay Goel. Andrographis overcomes 5-fluorouracil-associated chemoresistance through inhibition of DKK1 in colorectal cancer. Carcinogenesis 2021; 42(6): 814 doi: 10.1093/carcin/bgab027
|
| 53 |
Dongdong Luo, Yuhang Zhang, Shuang Yang, Xiaochen Tian, Yan Lv, Zhikun Guo, Xiaochun Liu, Gaitian Han, Shuai Liu, Wenyu Wang, Shuxiang Cui, Xianjun Qu, Shengbiao Wan. Design, synthesis and biological evaluation of sphingosine-1-phosphate receptor 2 antagonists as potent 5-FU-resistance reversal agents for the treatment of colorectal cancer. European Journal of Medicinal Chemistry 2021; 225: 113775 doi: 10.1016/j.ejmech.2021.113775
|
| 54 |
Erfan Zaker, Negar Nouri, Sepehr Sorkhizadeh, Hamidreza Ghasemirad, Amir Hossein Hajijafari, Fateme Zare. The importance of personalized medicine in chronic myeloid leukemia management: a narrative review. Egyptian Journal of Medical Human Genetics 2023; 24(1) doi: 10.1186/s43042-023-00411-3
|
| 55 |
Shen-Jeu Won, Ting-Yu Lin, Cheng-Hsin Yen, Yu-Hau Tzeng, Hsiao-Sheng Liu, Chun-Nan Lin, Cheng-Hao Yu, Chi-Shiuan Wu, Jyun-Ti Chen, Yi-Ting Chen, Chi-Ying F. Huang, Chun-Li Su. A novel natural tautomeric pair of garcinielliptone FC suppressed nuclear factor κB and induced apoptosis in human colorectal cancer cells. Journal of Functional Foods 2016; 24: 568 doi: 10.1016/j.jff.2016.05.003
|
| 56 |
Ghada Al Bayyat, Dan Arreaza-Kaufman, Nandini Venkateswaran, Anat Galor, Carol L. Karp. Update on pharmacotherapy for ocular surface squamous neoplasia. Eye and Vision 2019; 6(1) doi: 10.1186/s40662-019-0150-5
|
| 57 |
Karolina Tecza, Jolanta Pamula-Pilat, Joanna Lanuszewska, Dorota Butkiewicz, Ewa Grzybowska. Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients. Oncotarget 2018; 9(10): 9114 doi: 10.18632/oncotarget.24148
|
| 58 |
Anggraeni E. Kusumaningrum, Sarce Makaba, Eyhab Ali, Mandeep Singh, Mohammed N. Fenjan, Irodakhon Rasulova, Neeti Misra, Sada G. Al‐ Musawi, Ali Alsalamy. A perspective on emerging therapies in metastatic colorectal cancer: Focusing on molecular medicine and drug resistance. Cell Biochemistry and Function 2024; 42(1) doi: 10.1002/cbf.3906
|
| 59 |
Erika Cecchin, Elena De Mattia, Fabrizio Ecca, Giuseppe Toffoli. Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation. Drug Resistance Updates 2018; 39: 18 doi: 10.1016/j.drup.2018.07.001
|
| 60 |
Inna Zubrilov, Orit Sagi-Assif, Sivan Izraely, Tsipi Meshel, Shlomit Ben-Menahem, Ravit Ginat, Metsada Pasmanik-Chor, Clara Nahmias, Pierre-Olivier Couraud, Dave S.B. Hoon, Isaac P. Witz. Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells. Cancer Letters 2015; 361(1): 86 doi: 10.1016/j.canlet.2015.02.041
|
| 61 |
Xing He, Jun Tang, He-Zhong Yan, Jiao-Xue Wang, Hai-Qing Li, Xiao-Wei Duan, Sen-Yuan Yu, Xi-Lu Hou, Guo-Bin Liao, Wei Liu. Anemoside B4 sensitizes human colorectal cancer to fluorouracil-based chemotherapy through src-mediated cell apoptosis. Aging 2021; 13(23): 25365 doi: 10.18632/aging.203751
|
| 62 |
Abdurakhim Toychiev, Sulayman Abdujapparov, Alim Imamov, Behzod Navruzov, Nikolay Davis, Najiya Badalova, Svetlana Osipova. Intestinal helminths and protozoan infections in patients with colorectal cancer: prevalence and possible association with cancer pathogenesis. Parasitology Research 2018; 117(12): 3715 doi: 10.1007/s00436-018-6070-9
|
| 63 |
Zeynep N. Erdem, Stefanie Schwarz, Daniel Drev, Christine Heinzle, Andrea Reti, Petra Heffeter, Xenia Hudec, Klaus Holzmann, Bettina Grasl-Kraupp, Walter Berger, Michael Grusch, Brigitte Marian. Irinotecan Upregulates Fibroblast Growth Factor Receptor 3 Expression in Colorectal Cancer Cells, Which Mitigates Irinotecan-Induced Apoptosis. Translational Oncology 2017; 10(3): 332 doi: 10.1016/j.tranon.2017.02.004
|
| 64 |
Wenjun Hu, Linping Lei, Xuqin Xie, Libin Huang, Qian Cui, Tang Dang, Gang Logan Liu, Yuan Li, Xiaofeng Sun, Zongguang Zhou. Heterogeneous nuclear ribonucleoprotein L facilitates recruitment of 53BP1 and BRCA1 at the DNA break sites induced by oxaliplatin in colorectal cancer. Cell Death & Disease 2019; 10(8) doi: 10.1038/s41419-019-1784-x
|
| 65 |
RWK Wu, CMN Yow, Eric Law, ESM Chu, Zheng Huang. Effect of Foslip® mediated photodynamic therapy on 5-fluorouracil resistant human colorectal cancer cells. Photodiagnosis and Photodynamic Therapy 2020; 31: 101945 doi: 10.1016/j.pdpdt.2020.101945
|
| 66 |
Guoying Jin, Yuhang Liu, Jia Zhang, Zehua Bian, Surui Yao, Bojian Fei, Leyuan Zhou, Yuan Yin, Zhaohui Huang. A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer. Cancer Chemotherapy and Pharmacology 2019; 84(2): 315 doi: 10.1007/s00280-019-03867-6
|
| 67 |
Wensong Yao, Zhen Lin, Peiying Shi, Bing Chen, Gang Wang, Jianyong Huang, Yuxia Sui, Qicai Liu, Shaoguang Li, Xinhua Lin, Qicai Liu, Hong Yao. Delicaflavone induces ROS-mediated apoptosis and inhibits PI3K/AKT/mTOR and Ras/MEK/Erk signaling pathways in colorectal cancer cells. Biochemical Pharmacology 2020; 171: 113680 doi: 10.1016/j.bcp.2019.113680
|
| 68 |
Jorge Hernando-Cubero, Ignacio Matos-García, Vicente Alonso-Orduña, Jaume Capdevila. The Role of Fluoropirimidines in Gastrointestinal Tumours: from the Bench to the Bed. Journal of Gastrointestinal Cancer 2017; 48(2): 135 doi: 10.1007/s12029-017-9946-5
|
| 69 |
Chunyan Zhang, Jie Zheng, Jin Liu, Yanxia Li, Guoqiang Xing, Shupeng Zhang, Hekai Chen, Jian Wang, Zhijiang Shao, Yongyuan Li, Zhongmin Jiang, Yingzi Pan, Xiaozhi Liu, Ping Xu, Wenhan Wu. Pan-cancer analyses reveal the molecular and clinical characteristics of TET family members and suggests that TET3 maybe a potential therapeutic target. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1418456
|
| 70 |
Yongfeng Guo, Bing Han, Kongliang Luo, Zhijian Ren, Lei Cai, Li Sun. NOX2-ROS-HIF-1α signaling is critical for the inhibitory effect of oleanolic acid on rectal cancer cell proliferation. Biomedicine & Pharmacotherapy 2017; 85: 733 doi: 10.1016/j.biopha.2016.11.091
|
| 71 |
Michal Hendrych, Kamila Říhová, Barbora Adamová, Vojtěch Hradil, Marek Stiborek, Petr Vlček, Markéta Hermanová, Jana Vašíčková, Petr Beneš, Jan Šmarda, Viktor Kanický, Jan Preisler, Jarmila Navrátilová. Disulfiram increases the efficacy of 5-fluorouracil in organotypic cultures of colorectal carcinoma. Biomedicine & Pharmacotherapy 2022; 153: 113465 doi: 10.1016/j.biopha.2022.113465
|
| 72 |
Ki Heon Choi, Joohee Jung. Anti-proliferation Effect of Coscinoderma sp. Extract on Human Colon Cancer Cells. Journal of Food Hygiene and Safety 2016; 31(4): 294 doi: 10.13103/JFHS.2016.31.4.294
|
| 73 |
Amirsaeed Sabeti Aghabozorgi, Mostafa Moradi Sarabi, Reza Jafarzadeh-Esfehani, Shabnaz Koochakkhani, Marziyeh Hassanzadeh, Soudabeh Kavousipour, Ebrahim Eftekhar. Molecular determinants of response to 5-fluorouracil-based chemotherapy in colorectal cancer: The undisputable role of micro-ribonucleic acids. World Journal of Gastrointestinal Oncology 2020; 12(9): 942-956 doi: 10.4251/wjgo.v12.i9.942
|
| 74 |
Abdulrahman A. Zuraik, Yaman Daboul, M. Ayman Awama, Haitham Yazigi, Moh’d Azzam Kayasseh, Michael Georges. Effect of Chemotherapy on Fusobacterium nucleatum Abundance in Colorectal Cancer Patients: A Study on Relapsing Patients. Indian Journal of Microbiology 2024; doi: 10.1007/s12088-024-01279-6
|
| 75 |
Heather F. Sinner, Jeremy Johnson, Piotr G. Rychahou, David S. Watt, Yekaterina Y. Zaytseva, Chunming Liu, B. Mark Evers, Javier S Castresana. Novel chemotherapeutic agent, FND-4b, activates AMPK and inhibits colorectal cancer cell proliferation. PLOS ONE 2019; 14(10): e0224253 doi: 10.1371/journal.pone.0224253
|
| 76 |
Ayat B. Al-Ghafari, Khadijah S. Balamash, Huda A. Al Doghaither. Relationship between Serum Vitamin D and Calcium Levels and Vitamin D Receptor Gene Polymorphisms in Colorectal Cancer. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/8571541
|
| 77 |
Wei Wu, Ke He, Qian Guo, Jingdi Chen, Mengjiao Zhang, Kai Huang, Dongmei Yang, Lu Wu, Yunchao Deng, Xu Luo, Honggang Yu, Qianshan Ding, Guoan Xiang. SSRP1 promotes colorectal cancer progression and is negatively regulated by miR‐28‐5p. Journal of Cellular and Molecular Medicine 2019; 23(5): 3118 doi: 10.1111/jcmm.14134
|
| 78 |
Khalid Alhazzani, Thiagarajan Venkatesan, Umamaheswari Natarajan, Mohammad Algahtani, Ali Alaseem, Saad Alobid, Appu Rathinavelu. Evaluation of antitumor effects of VEGFR-2 inhibitor F16 in a colorectal xenograft model. Biotechnology Letters 2022; 44(5-6): 787 doi: 10.1007/s10529-022-03243-0
|
| 79 |
David I. Cantor, Harish R. Cheruku, Jack Westacott, Joo-Shik Shin, Abidali Mohamedali, Seong Boem Ahn. Proteomic investigations into resistance in colorectal cancer. Expert Review of Proteomics 2020; 17(1): 49 doi: 10.1080/14789450.2020.1713103
|
| 80 |
Yanping Guan, Yuanyuan Fu, Yao Liu, Siyi Wang, Man Zhao, Zhongming Jin, Fulin Jiang, Liang Hong, Min Huang, Min Li, Guoping Zhong. Quantitative Bioanalytical LC–MS/MS Assay for S130 in Rat Plasma-Application to a Pharmacokinetic Study. Bioanalysis 2019; 11(16): 1469 doi: 10.4155/bio-2019-0101
|
| 81 |
Prashanth Gokare, Niklas K. Finnberg, Phillip H. Abbosh, Jenny Dai, Maureen E. Murphy, Wafik S. El-Deiry. P53 represses pyrimidine catabolic gene dihydropyrimidine dehydrogenase (DPYD) expression in response to thymidylate synthase (TS) targeting. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-09859-x
|
| 82 |
Meng-Die Yang, Wen-Jun Zhou, Xiao-Le Chen, Jian Chen, Qing Ji, Qi Li, Wen-Hai Wang, Shi-Bing Su. Therapeutic Effect and Mechanism of Bushen-Jianpi-Jiedu Decoction Combined with Chemotherapeutic Drugs on Postoperative Colorectal Cancer. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.524663
|
| 83 |
Yong Yang, Guoxin Wang, Dajian Zhu, Yanfeng Huang, Yong Luo, Pengfei Su, Xiaowu Chen, Qian Wang. Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancer. International Journal of Oncology 2017; 51(2): 515 doi: 10.3892/ijo.2017.4044
|
| 84 |
Xin Xie, Yu Zhao, Chun‐Yan Ma, Xiao‐Ming Xu, Yan‐Qiu Zhang, Chen‐Guang Wang, Jing Jin, Xin Shen, Jin‐Lai Gao, Na Li, Zhi‐Jie Sun, De‐Li Dong. Dimethyl fumarate induces necroptosis in colon cancer cells through GSH depletion/ROS increase/MAPKs activation pathway. British Journal of Pharmacology 2015; 172(15): 3929 doi: 10.1111/bph.13184
|
| 85 |
Jun Zou, Weihua Kuang, Jilong Hu, Huamin Rao. miR-216b promotes cell growth and enhances chemosensitivity of colorectal cancer by suppressing PDZ-binding kinase. Biochemical and Biophysical Research Communications 2017; 488(2): 247 doi: 10.1016/j.bbrc.2017.03.162
|
| 86 |
Jingbo Yang, Chengyan He, Ning Liu. Proteomic analysis of the chemosensitizing effect of curcumin on CRC cells treated with 5-FU. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.1032256
|
| 87 |
Miguel Cordova-Delgado, María Loreto Bravo, Elisa Cumsille, Charlotte N. Hill, Matías Muñoz-Medel, Mauricio P. Pinto, Ignacio N. Retamal, María A. Lavanderos, Juan Francisco Miquel, Maria Rodriguez-Fernandez, Yuwei Liao, Zhiguang Li, Alejandro H. Corvalán, Ricardo Armisén, Marcelo Garrido, Luis A. Quiñones, Gareth I. Owen. A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherapy in gastric cancer. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08745-0
|
| 88 |
Lin-Lin Cao, Hangqi Liu, Zhihong Yue, Lianhua Liu, Lin Pei, Junxu Gu, Hui Wang, Mei Jia. Iron chelation inhibits cancer cell growth and modulates global histone methylation status in colorectal cancer. BioMetals 2018; 31(5): 797 doi: 10.1007/s10534-018-0123-5
|
| 89 |
Qiang Wang, Yan-long Shi, Kai Zhou, Li-li Wang, Ze-xuan Yan, Yu-lin Liu, Li-li Xu, Shi-wei Zhao, Hui-li Chu, Ting-ting Shi, Qing-hua Ma, Jingwang Bi. PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer. Cell Death & Disease 2018; 9(7) doi: 10.1038/s41419-018-0776-6
|
| 90 |
Henu Kumar Verma, Yashwant Kumar Ratre, Pellegrino Mazzone. Colon Cancer Diagnosis and Therapy Vol. 3. 2022; : 123 doi: 10.1007/978-3-030-72702-4_7
|
| 91 |
Cheng-Zhi Huang, Yue Zhou, Qi-Song Tong, Qi-Jia Duan, Qing Zhang, Jin-Zhi Du, Xue-Qing Yao. Precision medicine-guided co-delivery of ASPN siRNA and oxaliplatin by nanoparticles to overcome chemoresistance of colorectal cancer. Biomaterials 2022; 290: 121827 doi: 10.1016/j.biomaterials.2022.121827
|
| 92 |
J.A. Willis, E. Vilar. Pharmacogenomics: time to rethink its role in precision medicine. Annals of Oncology 2018; 29(2): 293 doi: 10.1093/annonc/mdx780
|
| 93 |
Guolin Zhang, Xin Luo, Wei Zhang, Engeng Chen, Jianbin Xu, Fei Wang, Gaoyang Cao, Zhenyu Ju, Dongai Jin, Xuefeng Huang, Wei Zhou, Zhangfa Song. CXCL-13 Regulates Resistance to 5-Fluorouracil in Colorectal Cancer. Cancer Research and Treatment 2020; 52(2): 622 doi: 10.4143/crt.2019.593
|
| 94 |
Yi Zheng, Qin Ouyang, Ruoqiu Fu, Lei Liu, Hongwei Zhang, Xiaoye Hu, Yanxia Liu, Yingchun Chen, Ning Gao. The cyclohexene derivative MC-3129 exhibits antileukemic activity via RhoA/ROCK1/PTEN/PI3K/Akt pathway-mediated mitochondrial translocation of cofilin. Cell Death & Disease 2018; 9(6) doi: 10.1038/s41419-018-0689-4
|
| 95 |
Alireza Mafi, Neda Hedayati, Yaser Eshaghi Milasi, Samaneh Kahkesh, Minoo Daviran, Najma Farahani, Mehrdad Hashemi, Noushin Nabavi, Mina Alimohammadi, Payman Rahimzadeh, Afshin Taheriazam. The function and mechanism of circRNAs in 5-fluorouracil resistance in tumors: Biological mechanisms and future potential. Pathology - Research and Practice 2024; 260: 155457 doi: 10.1016/j.prp.2024.155457
|
| 96 |
Hanane Akhdar, Said El Shamieh, Orlando Musso, Romain Désert, Wissam Joumaa, Dominique Guyader, Caroline Aninat, Anne Corlu, Fabrice Morel, Matias A. Avila. The rs3957357C>T SNP in GSTA1 Is Associated with a Higher Risk of Occurrence of Hepatocellular Carcinoma in European Individuals. PLOS ONE 2016; 11(12): e0167543 doi: 10.1371/journal.pone.0167543
|
| 97 |
Sara Gagno, Michele Bartoletti, Chiara Romualdi, Elena Poletto, Simona Scalone, Roberto Sorio, Martina Zanchetta, Elena De Mattia, Rossana Roncato, Erika Cecchin, Giorgio Giorda, Giuseppe Toffoli. Pharmacogenetic Score Predicts Overall Survival, Progression-Free Survival and Platinum Sensitivity in Ovarian Cancer. Pharmacogenomics 2020; 21(14): 995 doi: 10.2217/pgs-2020-0049
|
| 98 |
Jun Ma, Guangyi Gao, Hong Lu, Dong Fang, Lingchang Li, Guoli Wei, Aifei Chen, Yong Yang, Hongying Zhang, Jiege Huo. Reversal effect of ginsenoside Rh2 on oxaliplatin‑resistant colon cancer cells and its mechanism. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7604
|
| 99 |
Xiaoli Zhang, Shuhua Shan, Hanqing Li, Jiangying Shi, Yang Lu, Zhuoyu Li. Cloning, expression of the truncation of recombinant peroxidase derived from millet bran and its reversal effects on 5-Fu resistance in colorectal cancer. International Journal of Biological Macromolecules 2019; 132: 871 doi: 10.1016/j.ijbiomac.2019.03.111
|